March 22, 2025

The March 2025 News from ECOG-ACRIN blog is now available

March 5, 2025

LISTEN: A JAMA Network Learning podcast interview with Dr. Anand Jillella, author of the newly published results of study EA9131 in JAMA Oncology

February 25, 2025

Top trial results of 2024: A year of significant advancements in cancer treatment by ECOG-ACRIN and PrECOG

February 6, 2025

“I was delighted when I saw the results. Positive phase 3 trials in glioma are a rarity.” David Schiff on the results of E3F05

January 17, 2025

The Winter 2025 advocacy blog Considering Clinical Trials is now available

January 10, 2025

Adjuvant tamoxifen reduces 15-year risk of recurrence in ‘good risk’ DCIS without radiation therapy (mentions E5194)

December 12, 2024

Press Release: Adjuvant tamoxifen may reduce recurrence risk for patients with ‘good-risk’ DCIS who forgo radiation

December 10, 2024

Press Release: Autologous stem cell transplants do not improve survival for mantle cell lymphoma patients with undetectable MRD, clinical trial shows

December 4, 2024

Upfront treatment and early intervention to get attention at ASH 2024, including mantle cell lymphoma with the striking results of study EA4151

ECOG-ACRIN Cancer Research Group